# A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

> **NCT01195324** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Canagliflozin/Warfarin
- **DRUG:** Canagliflozin/Warfarin

## Key facts

- **NCT ID:** NCT01195324
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01195324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01195324, "A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01195324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*